The Influence of Antibiotics on the Incidence of Biliary Tract Infections After PTCD for Malignant Obstructive Jaundice
- Conditions
- The Influence of Antibiotics on the Incidence of Biliary Tract Infections After PTCD for Malignant Obstructive Jaundice
- Interventions
- Other: antibiotic
- Registration Number
- NCT04620577
- Lead Sponsor
- Xian-Jun Yu
- Brief Summary
To investigate the influence of antibiotics on the incidence of biliary tract infections after PTCD for malignant obstructive jaundice.
- Detailed Description
This project designed a large-scale, single-center, prospective randomized controlled clinical trial to explore the impact of antibiotics on the incidence of biliary tract infections after PTCD with malignant obstructive jaundice. This study will provide evidence-based medical evidence for the need for routine use of antibiotics to prevent biliary tract infections after PTCD with malignant obstructive jaundice, and provide references for clinicians to prevent patients from PTCD infections.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 120
- 18-80 years old;
- ECOG score 0-1 before operation;
- Patients diagnosed as pancreatic head cancer and periampullary cancer according to preoperative imaging, including ampullary cancer, extrahepatic bile duct cancer and duodenal papillary cancer;
- Bilirubin>200 mmol/L before PTCD , and the duration of PTCD continuous drainage >2 weeks;
- Volunteer to participate and sign the informed consent form;
- Decompensated liver cirrhosis, acute and chronic hepatitis and other diseases before surgery;
- A history of other malignant tumors before surgery;
- Duration of preoperative PTCD drainage<2 weeks;
- Jaundice caused by other reasons besides cancer around the ampulla and cancer of the head of the pancreas;
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Antibiotic group antibiotic Infusion of ceftriaxone sodium needle (2g, solvent 100ml normal saline) within 1h before and 12h after PTCD. No-antibiotic group antibiotic Infusion of Normal saline within 1h before and 12h after PTCD.
- Primary Outcome Measures
Name Time Method Incidence of patients with biliary tract infection after surgery October 2020 to June 2023 Incidence of patients with biliary tract infection after surgery
- Secondary Outcome Measures
Name Time Method Decline rate of bilirubin in patients after PTCD October 2020 to June 2023 Decline rate of bilirubin in patients after PTCD
Trial Locations
- Locations (1)
Department of Pancreatic and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University
🇨🇳Shanghai, Shanghai, China